Apo-E genotype and verbal deficits in Alzheimer's disease



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via Google Scholar



	Articles by Rasmusson, D. X.
	Articles by Lyketsos, C.
	Search for Related Content



	PubMed Citation
	Articles by Rasmusson, D. X.
	Articles by Lyketsos, C.

J Neuropsychiatry Clin Neurosci 1996; 8:335-337
Copyright © 1996 by American Neuropsychiatric Association

REGULAR ARTICLES

Apo-E genotype and verbal deficits in Alzheimer's disease

DX Rasmusson, G Dal Forno, J Brandt, AC Warren, J Troncoso and C Lyketsos
Department of Psychiatry/Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. xeno@mvx.grc.nia.nih.gov

Apo-E genotype was not significantly related to cognitive performance in 157 Alzheimer's disease patients. However, patients homozygous for the epsilon 4 allele appeared most impaired on global cognition but least impaired on language measures. Further study with larger samples may reveal that Apo-E genotype accounts for some of the variability in cognitive deficits observed in Alzheimer's disease.

Get information about faster international access.